Retatrutide appears to be a new treatment in the fight against obesity. This novel drug, classified as a dual GLP-1 and GIP receptor agonist, shows promising results in clinical trials. By stimulating these https://georgiafeeh192189.blogpayz.com/36359994/tirzepatide-a-promising-new-treatment-for-obesity